JAZZ PHA reported $63.89M in Interest Expense on Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 1.64M 0M
ALKERMES ALKS:US 2.37M 19K
Eli Lilly And LLY:US $ 81.2M 3.7M
Emergent Biosolutions EBS:US $ 7.8M 0.4M
Halozyme Therapeutics HALO:US $ 3.1M 1.34M
IONIS PHARMACEUT IONS:US $ 2.13M 0.01M
Lannett LCI:US $ 14.81M 0.29M
Mckesson MCK:US $ 45M 2M
Nektar Therapeutics NKTR:US $ 7.23M 0.3M
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Pfizer PFE:US $ 293M 29M
Revance Therapeutics RVNC:US $ 3.87M 1.94M
Supernus Pharmaceuticals SUPN:US $ 1.81M 0.66M
Teva Pharmaceutical Industries TEVA:US $ 225M 13M
Xeris Pharmaceuticals Inc XERS:US $ 3.45M 73K
Zoetis ZTS:US $ 53M 0M